POTASSIUM CHLORIDE 20 mmol in SODIUM CHLORIDE 0.9% 1000 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 20 mmol in sodium chloride 0.9% 1000 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - sodium chloride, quantity: 9 g/l; potassium chloride, quantity: 1.5 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE 14.9 % Israel - English - Ministry of Health

potassium chloride 14.9 %

lapidot medical import and marketing ltd - potassium chloride - concentrate for solution for infusion - potassium chloride 14.9 g / 100 ml - potassium chloride - potassium chloride - treatment of potassium deficiency states when oral replacement is not feasable.

POTASSIUM CHLORIDE tablet, extended release United States - English - NLM (National Library of Medicine)

potassium chloride tablet, extended release

aphena pharma solutions - tennessee, llc - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - potassium cation 20 meq - because of reports of intestinal and gastric ulceration and bleeding with controlled-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations or for patients in whom there is a problem of compliance with these preparations. 1.    for the treatment of patients with hypokalemia with or without metabolic alkalosis, in digitalis intoxication, and in patients with hypokalemic familial periodic paralysis. if hypokalemia is the result of diuretic therapy, consideration should be given to the use of a lower dose of diuretic, which may be sufficient without leading to hypokalemia. 2.    for the prevention of hypokalemia in patients who would be at particular risk if hypokalemia were to develop, eg, digitalized patients or patients with significant cardiac arrhythmias. the use of potassium salts in patients receiving diuretics for uncomplicated essential hypertension is often unnecessary when such patie

Potassium chloride 20% (potassium 13.3mmol/5ml) solution for infusion 5ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 20% (potassium 13.3mmol/5ml) solution for infusion 5ml ampoules

potassium 13.3mmol/5ml) solution for infusion 5ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml

Potassium chloride 20% (potassium 27mmol/10ml) solution for infusion 10ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 20% (potassium 27mmol/10ml) solution for infusion 10ml ampoules

potassium 27mmol/10ml) solution for infusion 10ml ampoules (martindale pharmaceuticals ltd - potassium chloride - solution for infusion - 200mg/1ml

Strong Potassium Chloride Solution B.P. 1.5g in 10mL Australia - English - Department of Health (Therapeutic Goods Administration)

strong potassium chloride solution b.p. 1.5g in 10ml

pfizer australia pty ltd - potassium chloride -

POTASSIUM CHLORIDE solution United States - English - NLM (National Library of Medicine)

potassium chloride solution

atlantic biologicals corps - potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698) - potassium chloride 20 meq in 15 ml - potassium chloride is indicated for the treatment and prophylaxis of hypokalemia in patients for whom dietary management with potassium-rich foods or diuretic dose reduction are insufficient. potassium chloride is contraindicated in patients on potassium sparing diuretics pregnancy category c animal reproduction studies have not been conducted with potassium chloride. it is unlikely that potassium supplementation that does not lead to hyperkalemia would have an adverse effect on the fetus or would affect reproductive capacity. the normal potassium ion content of human milk is about 13 meq per liter. since oral potassium becomes part of the body potassium pool, so long as body potassium is not excessive, the contribution of potassium chloride supplementation should have little or no effect on the level in human milk. the safety and effectiveness of potassium chloride have been demonstrated in children with diarrhea and malnutrition from birth to18 years. clinical studies of potassium chloride did not include s

POTASSIUM CHLORIDE 10 mmol in SODIUM CHLORIDE 0.9% 500 mL injection for intravenous infusion bottle Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride 10 mmol in sodium chloride 0.9% 500 ml injection for intravenous infusion bottle

fresenius kabi australia pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; hydrochloric acid - a source of water and to restore electrolyte balance as required by a patient's clinical condition, such as hypokalaemia

POTASSIUM CHLORIDE JUNO Potassium Chloride 2g/10mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride juno potassium chloride 2g/10ml injection

juno pharmaceuticals pty ltd - potassium chloride, quantity: 200 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia. 2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.

POTASSIUM CHLORIDE JUNO Potassium Chloride 1g/10mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

potassium chloride juno potassium chloride 1g/10ml injection ampoule

juno pharmaceuticals pty ltd - potassium chloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia.2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.